Global Human Cytomegalovirus Envelope Glycoprotein B Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Human Cytomegalovirus Envelope Glycoprotein B market size was valued at US$ million in 2023. With growing demand in downstream market, the Human Cytomegalovirus Envelope Glycoprotein B is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Human Cytomegalovirus Envelope Glycoprotein B market. Human Cytomegalovirus Envelope Glycoprotein B are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Human Cytomegalovirus Envelope Glycoprotein B. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Human Cytomegalovirus Envelope Glycoprotein B market.
Key Features:
The report on Human Cytomegalovirus Envelope Glycoprotein B market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Human Cytomegalovirus Envelope Glycoprotein B market. It may include historical data, market segmentation by Type (e.g., CSJ-148, CyMVectin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Human Cytomegalovirus Envelope Glycoprotein B market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Human Cytomegalovirus Envelope Glycoprotein B market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Human Cytomegalovirus Envelope Glycoprotein B industry. This include advancements in Human Cytomegalovirus Envelope Glycoprotein B technology, Human Cytomegalovirus Envelope Glycoprotein B new entrants, Human Cytomegalovirus Envelope Glycoprotein B new investment, and other innovations that are shaping the future of Human Cytomegalovirus Envelope Glycoprotein B.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Human Cytomegalovirus Envelope Glycoprotein B market. It includes factors influencing customer ' purchasing decisions, preferences for Human Cytomegalovirus Envelope Glycoprotein B product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Human Cytomegalovirus Envelope Glycoprotein B market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Human Cytomegalovirus Envelope Glycoprotein B market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Human Cytomegalovirus Envelope Glycoprotein B market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Human Cytomegalovirus Envelope Glycoprotein B industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Human Cytomegalovirus Envelope Glycoprotein B market.
Market Segmentation:
Human Cytomegalovirus Envelope Glycoprotein B market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Human Cytomegalovirus Envelope Glycoprotein B market?
What factors are driving Human Cytomegalovirus Envelope Glycoprotein B market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Cytomegalovirus Envelope Glycoprotein B market opportunities vary by end market size?
How does Human Cytomegalovirus Envelope Glycoprotein B break out type, application?
According to our LPI (LP Information) latest study, the global Human Cytomegalovirus Envelope Glycoprotein B market size was valued at US$ million in 2023. With growing demand in downstream market, the Human Cytomegalovirus Envelope Glycoprotein B is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Human Cytomegalovirus Envelope Glycoprotein B market. Human Cytomegalovirus Envelope Glycoprotein B are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Human Cytomegalovirus Envelope Glycoprotein B. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Human Cytomegalovirus Envelope Glycoprotein B market.
Key Features:
The report on Human Cytomegalovirus Envelope Glycoprotein B market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Human Cytomegalovirus Envelope Glycoprotein B market. It may include historical data, market segmentation by Type (e.g., CSJ-148, CyMVectin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Human Cytomegalovirus Envelope Glycoprotein B market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Human Cytomegalovirus Envelope Glycoprotein B market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Human Cytomegalovirus Envelope Glycoprotein B industry. This include advancements in Human Cytomegalovirus Envelope Glycoprotein B technology, Human Cytomegalovirus Envelope Glycoprotein B new entrants, Human Cytomegalovirus Envelope Glycoprotein B new investment, and other innovations that are shaping the future of Human Cytomegalovirus Envelope Glycoprotein B.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Human Cytomegalovirus Envelope Glycoprotein B market. It includes factors influencing customer ' purchasing decisions, preferences for Human Cytomegalovirus Envelope Glycoprotein B product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Human Cytomegalovirus Envelope Glycoprotein B market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Human Cytomegalovirus Envelope Glycoprotein B market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Human Cytomegalovirus Envelope Glycoprotein B market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Human Cytomegalovirus Envelope Glycoprotein B industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Human Cytomegalovirus Envelope Glycoprotein B market.
Market Segmentation:
Human Cytomegalovirus Envelope Glycoprotein B market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- CSJ-148
- CyMVectin
- TRL-345
- PPCM
- Cytomegalovirus Vaccine
- Others
- Infectious Disease
- Oncology
- Women's Health
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Astellas Pharma Inc.
- Trellis Bioscience, Inc.
- Vakzine Projekt Management GmbH
- VBI Vaccine Inc
- Vical Incorporated
What is the 10-year outlook for the global Human Cytomegalovirus Envelope Glycoprotein B market?
What factors are driving Human Cytomegalovirus Envelope Glycoprotein B market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Cytomegalovirus Envelope Glycoprotein B market opportunities vary by end market size?
How does Human Cytomegalovirus Envelope Glycoprotein B break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Human Cytomegalovirus Envelope Glycoprotein B by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Human Cytomegalovirus Envelope Glycoprotein B by Country/Region, 2019, 2023 & 2030
2.2 Human Cytomegalovirus Envelope Glycoprotein B Segment by Type
2.2.1 CSJ-148
2.2.2 CyMVectin
2.2.3 TRL-345
2.2.4 PPCM
2.2.5 Cytomegalovirus Vaccine
2.2.6 Others
2.3 Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
2.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2024)
2.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Type (2019-2024)
2.3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Type (2019-2024)
2.4 Human Cytomegalovirus Envelope Glycoprotein B Segment by Application
2.4.1 Infectious Disease
2.4.2 Oncology
2.4.3 Women's Health
2.4.4 Others
2.5 Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
2.5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Market Share by Application (2019-2024)
2.5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Application (2019-2024)
2.5.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Application (2019-2024)
3 GLOBAL HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B BY COMPANY
3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Breakdown Data by Company
3.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Company (2019-2024)
3.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2019-2024)
3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Company (2019-2024)
3.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Company (2019-2024)
3.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company (2019-2024)
3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Company
3.4 Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Product Location Distribution
3.4.2 Players Human Cytomegalovirus Envelope Glycoprotein B Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B BY GEOGRAPHIC REGION
4.1 World Historic Human Cytomegalovirus Envelope Glycoprotein B Market Size by Geographic Region (2019-2024)
4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country/Region (2019-2024)
4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Country/Region (2019-2024)
4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Country/Region (2019-2024)
4.3 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
4.4 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
4.5 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
4.6 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
5 AMERICAS
5.1 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
5.1.1 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024)
5.1.2 Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024)
5.2 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
5.3 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
6.1.1 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2019-2024)
6.1.2 APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2019-2024)
6.2 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
6.3 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Cytomegalovirus Envelope Glycoprotein B by Country
7.1.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024)
7.1.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024)
7.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
7.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B by Country
8.1.1 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024)
8.1.2 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024)
8.2 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
8.3 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B
10.3 Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
10.4 Industry Chain Structure of Human Cytomegalovirus Envelope Glycoprotein B
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors
11.3 Human Cytomegalovirus Envelope Glycoprotein B Customer
12 WORLD FORECAST REVIEW FOR HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B BY GEOGRAPHIC REGION
12.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Region
12.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Region (2025-2030)
12.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Type
12.7 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Astellas Pharma Inc.
13.1.1 Astellas Pharma Inc. Company Information
13.1.2 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Astellas Pharma Inc. Main Business Overview
13.1.5 Astellas Pharma Inc. Latest Developments
13.2 Trellis Bioscience, Inc.
13.2.1 Trellis Bioscience, Inc. Company Information
13.2.2 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Trellis Bioscience, Inc. Main Business Overview
13.2.5 Trellis Bioscience, Inc. Latest Developments
13.3 Vakzine Projekt Management GmbH
13.3.1 Vakzine Projekt Management GmbH Company Information
13.3.2 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Vakzine Projekt Management GmbH Main Business Overview
13.3.5 Vakzine Projekt Management GmbH Latest Developments
13.4 VBI Vaccine Inc
13.4.1 VBI Vaccine Inc Company Information
13.4.2 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 VBI Vaccine Inc Main Business Overview
13.4.5 VBI Vaccine Inc Latest Developments
13.5 Vical Incorporated
13.5.1 Vical Incorporated Company Information
13.5.2 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Vical Incorporated Main Business Overview
13.5.5 Vical Incorporated Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Human Cytomegalovirus Envelope Glycoprotein B by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Human Cytomegalovirus Envelope Glycoprotein B by Country/Region, 2019, 2023 & 2030
2.2 Human Cytomegalovirus Envelope Glycoprotein B Segment by Type
2.2.1 CSJ-148
2.2.2 CyMVectin
2.2.3 TRL-345
2.2.4 PPCM
2.2.5 Cytomegalovirus Vaccine
2.2.6 Others
2.3 Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
2.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2024)
2.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Type (2019-2024)
2.3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Type (2019-2024)
2.4 Human Cytomegalovirus Envelope Glycoprotein B Segment by Application
2.4.1 Infectious Disease
2.4.2 Oncology
2.4.3 Women's Health
2.4.4 Others
2.5 Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
2.5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Market Share by Application (2019-2024)
2.5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Market Share by Application (2019-2024)
2.5.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Application (2019-2024)
3 GLOBAL HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B BY COMPANY
3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Breakdown Data by Company
3.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Company (2019-2024)
3.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2019-2024)
3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Company (2019-2024)
3.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Company (2019-2024)
3.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company (2019-2024)
3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Company
3.4 Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Product Location Distribution
3.4.2 Players Human Cytomegalovirus Envelope Glycoprotein B Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B BY GEOGRAPHIC REGION
4.1 World Historic Human Cytomegalovirus Envelope Glycoprotein B Market Size by Geographic Region (2019-2024)
4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country/Region (2019-2024)
4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Sales by Country/Region (2019-2024)
4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue by Country/Region (2019-2024)
4.3 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
4.4 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
4.5 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
4.6 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Growth
5 AMERICAS
5.1 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country
5.1.1 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024)
5.1.2 Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024)
5.2 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
5.3 Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
6.1.1 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2019-2024)
6.1.2 APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2019-2024)
6.2 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
6.3 APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Cytomegalovirus Envelope Glycoprotein B by Country
7.1.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024)
7.1.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024)
7.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
7.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B by Country
8.1.1 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024)
8.1.2 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024)
8.2 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
8.3 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B
10.3 Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
10.4 Industry Chain Structure of Human Cytomegalovirus Envelope Glycoprotein B
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors
11.3 Human Cytomegalovirus Envelope Glycoprotein B Customer
12 WORLD FORECAST REVIEW FOR HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B BY GEOGRAPHIC REGION
12.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Forecast by Region
12.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Region (2025-2030)
12.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Type
12.7 Global Human Cytomegalovirus Envelope Glycoprotein B Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Astellas Pharma Inc.
13.1.1 Astellas Pharma Inc. Company Information
13.1.2 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Astellas Pharma Inc. Main Business Overview
13.1.5 Astellas Pharma Inc. Latest Developments
13.2 Trellis Bioscience, Inc.
13.2.1 Trellis Bioscience, Inc. Company Information
13.2.2 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Trellis Bioscience, Inc. Main Business Overview
13.2.5 Trellis Bioscience, Inc. Latest Developments
13.3 Vakzine Projekt Management GmbH
13.3.1 Vakzine Projekt Management GmbH Company Information
13.3.2 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Vakzine Projekt Management GmbH Main Business Overview
13.3.5 Vakzine Projekt Management GmbH Latest Developments
13.4 VBI Vaccine Inc
13.4.1 VBI Vaccine Inc Company Information
13.4.2 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 VBI Vaccine Inc Main Business Overview
13.4.5 VBI Vaccine Inc Latest Developments
13.5 Vical Incorporated
13.5.1 Vical Incorporated Company Information
13.5.2 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
13.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Vical Incorporated Main Business Overview
13.5.5 Vical Incorporated Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Cytomegalovirus Envelope Glycoprotein B Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Human Cytomegalovirus Envelope Glycoprotein B Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CSJ-148
Table 4. Major Players of CyMVectin
Table 5. Major Players of TRL-345
Table 6. Major Players of PPCM
Table 7. Major Players of Cytomegalovirus Vaccine
Table 8. Major Players of Others
Table 9. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2024) & (K Pcs)
Table 10. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2024)
Table 11. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2019-2024) & ($ million)
Table 12. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2019-2024)
Table 13. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Type (2019-2024) & (USD/Pcs)
Table 14. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2024) & (K Pcs)
Table 15. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2019-2024)
Table 16. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2019-2024)
Table 17. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2019-2024)
Table 18. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Application (2019-2024) & (USD/Pcs)
Table 19. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Company (2019-2024) & (K Pcs)
Table 20. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2019-2024)
Table 21. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Company (2019-2024) ($ Millions)
Table 22. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company (2019-2024)
Table 23. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Company (2019-2024) & (USD/Pcs)
Table 24. Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Producing Area Distribution and Sales Area
Table 25. Players Human Cytomegalovirus Envelope Glycoprotein B Products Offered
Table 26. Human Cytomegalovirus Envelope Glycoprotein B Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Geographic Region (2019-2024) & (K Pcs)
Table 30. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Geographic Region (2019-2024)
Table 31. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Country/Region (2019-2024) & (K Pcs)
Table 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country/Region (2019-2024)
Table 35. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024) & (K Pcs)
Table 38. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2019-2024)
Table 39. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024) & ($ Millions)
Table 40. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2019-2024)
Table 41. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2024) & (K Pcs)
Table 42. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2024) & (K Pcs)
Table 43. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2019-2024) & (K Pcs)
Table 44. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2019-2024)
Table 45. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2019-2024) & ($ Millions)
Table 46. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2019-2024)
Table 47. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2024) & (K Pcs)
Table 48. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2024) & (K Pcs)
Table 49. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024) & (K Pcs)
Table 50. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2019-2024)
Table 51. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024) & ($ Millions)
Table 52. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2019-2024)
Table 53. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2024) & (K Pcs)
Table 54. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2024) & (K Pcs)
Table 55. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024) & (K Pcs)
Table 56. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2019-2024)
Table 57. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024) & ($ Millions)
Table 58. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2019-2024)
Table 59. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2024) & (K Pcs)
Table 60. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2024) & (K Pcs)
Table 61. Key Market Drivers & Growth Opportunities of Human Cytomegalovirus Envelope Glycoprotein B
Table 62. Key Market Challenges & Risks of Human Cytomegalovirus Envelope Glycoprotein B
Table 63. Key Industry Trends of Human Cytomegalovirus Envelope Glycoprotein B
Table 64. Human Cytomegalovirus Envelope Glycoprotein B Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Human Cytomegalovirus Envelope Glycoprotein B Distributors List
Table 67. Human Cytomegalovirus Envelope Glycoprotein B Customer List
Table 68. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Region (2025-2030) & (K Pcs)
Table 69. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2025-2030) & (K Pcs)
Table 71. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Region (2025-2030) & (K Pcs)
Table 73. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2025-2030) & (K Pcs)
Table 75. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2025-2030) & (K Pcs)
Table 77. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Type (2025-2030) & (K Pcs)
Table 79. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 80. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Application (2025-2030) & (K Pcs)
Table 81. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 82. Astellas Pharma Inc. Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 83. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 84. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 85. Astellas Pharma Inc. Main Business
Table 86. Astellas Pharma Inc. Latest Developments
Table 87. Trellis Bioscience, Inc. Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 88. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 89. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 90. Trellis Bioscience, Inc. Main Business
Table 91. Trellis Bioscience, Inc. Latest Developments
Table 92. Vakzine Projekt Management GmbH Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 93. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 94. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 95. Vakzine Projekt Management GmbH Main Business
Table 96. Vakzine Projekt Management GmbH Latest Developments
Table 97. VBI Vaccine Inc Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 98. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 99. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 100. VBI Vaccine Inc Main Business
Table 101. VBI Vaccine Inc Latest Developments
Table 102. Vical Incorporated Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 103. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 104. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 105. Vical Incorporated Main Business
Table 106. Vical Incorporated Latest Developments
Table 1. Human Cytomegalovirus Envelope Glycoprotein B Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Human Cytomegalovirus Envelope Glycoprotein B Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CSJ-148
Table 4. Major Players of CyMVectin
Table 5. Major Players of TRL-345
Table 6. Major Players of PPCM
Table 7. Major Players of Cytomegalovirus Vaccine
Table 8. Major Players of Others
Table 9. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2024) & (K Pcs)
Table 10. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2024)
Table 11. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2019-2024) & ($ million)
Table 12. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2019-2024)
Table 13. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Type (2019-2024) & (USD/Pcs)
Table 14. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2024) & (K Pcs)
Table 15. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2019-2024)
Table 16. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2019-2024)
Table 17. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2019-2024)
Table 18. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Application (2019-2024) & (USD/Pcs)
Table 19. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Company (2019-2024) & (K Pcs)
Table 20. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company (2019-2024)
Table 21. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Company (2019-2024) ($ Millions)
Table 22. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company (2019-2024)
Table 23. Global Human Cytomegalovirus Envelope Glycoprotein B Sale Price by Company (2019-2024) & (USD/Pcs)
Table 24. Key Manufacturers Human Cytomegalovirus Envelope Glycoprotein B Producing Area Distribution and Sales Area
Table 25. Players Human Cytomegalovirus Envelope Glycoprotein B Products Offered
Table 26. Human Cytomegalovirus Envelope Glycoprotein B Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Geographic Region (2019-2024) & (K Pcs)
Table 30. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Geographic Region (2019-2024)
Table 31. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Country/Region (2019-2024) & (K Pcs)
Table 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country/Region (2019-2024)
Table 35. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024) & (K Pcs)
Table 38. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2019-2024)
Table 39. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024) & ($ Millions)
Table 40. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2019-2024)
Table 41. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2024) & (K Pcs)
Table 42. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2024) & (K Pcs)
Table 43. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2019-2024) & (K Pcs)
Table 44. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2019-2024)
Table 45. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2019-2024) & ($ Millions)
Table 46. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2019-2024)
Table 47. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2024) & (K Pcs)
Table 48. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2024) & (K Pcs)
Table 49. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024) & (K Pcs)
Table 50. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2019-2024)
Table 51. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024) & ($ Millions)
Table 52. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2019-2024)
Table 53. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2024) & (K Pcs)
Table 54. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2024) & (K Pcs)
Table 55. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024) & (K Pcs)
Table 56. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2019-2024)
Table 57. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024) & ($ Millions)
Table 58. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2019-2024)
Table 59. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2024) & (K Pcs)
Table 60. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2024) & (K Pcs)
Table 61. Key Market Drivers & Growth Opportunities of Human Cytomegalovirus Envelope Glycoprotein B
Table 62. Key Market Challenges & Risks of Human Cytomegalovirus Envelope Glycoprotein B
Table 63. Key Industry Trends of Human Cytomegalovirus Envelope Glycoprotein B
Table 64. Human Cytomegalovirus Envelope Glycoprotein B Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Human Cytomegalovirus Envelope Glycoprotein B Distributors List
Table 67. Human Cytomegalovirus Envelope Glycoprotein B Customer List
Table 68. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Region (2025-2030) & (K Pcs)
Table 69. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2025-2030) & (K Pcs)
Table 71. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Region (2025-2030) & (K Pcs)
Table 73. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2025-2030) & (K Pcs)
Table 75. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Country (2025-2030) & (K Pcs)
Table 77. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Type (2025-2030) & (K Pcs)
Table 79. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 80. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Forecast by Application (2025-2030) & (K Pcs)
Table 81. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 82. Astellas Pharma Inc. Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 83. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 84. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 85. Astellas Pharma Inc. Main Business
Table 86. Astellas Pharma Inc. Latest Developments
Table 87. Trellis Bioscience, Inc. Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 88. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 89. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 90. Trellis Bioscience, Inc. Main Business
Table 91. Trellis Bioscience, Inc. Latest Developments
Table 92. Vakzine Projekt Management GmbH Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 93. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 94. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 95. Vakzine Projekt Management GmbH Main Business
Table 96. Vakzine Projekt Management GmbH Latest Developments
Table 97. VBI Vaccine Inc Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 98. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 99. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 100. VBI Vaccine Inc Main Business
Table 101. VBI Vaccine Inc Latest Developments
Table 102. Vical Incorporated Basic Information, Human Cytomegalovirus Envelope Glycoprotein B Manufacturing Base, Sales Area and Its Competitors
Table 103. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolios and Specifications
Table 104. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 105. Vical Incorporated Main Business
Table 106. Vical Incorporated Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Cytomegalovirus Envelope Glycoprotein B
Figure 2. Human Cytomegalovirus Envelope Glycoprotein B Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of CSJ-148
Figure 10. Product Picture of CyMVectin
Figure 11. Product Picture of TRL-345
Figure 12. Product Picture of PPCM
Figure 13. Product Picture of Cytomegalovirus Vaccine
Figure 14. Product Picture of Others
Figure 15. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2023
Figure 16. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2019-2024)
Figure 17. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Infectious Disease
Figure 18. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Infectious Disease (2019-2024) & (K Pcs)
Figure 19. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Oncology
Figure 20. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Oncology (2019-2024) & (K Pcs)
Figure 21. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Women's Health
Figure 22. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Women's Health (2019-2024) & (K Pcs)
Figure 23. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Others
Figure 24. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Others (2019-2024) & (K Pcs)
Figure 25. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2023)
Figure 26. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application in 2023
Figure 27. Human Cytomegalovirus Envelope Glycoprotein B Sales Market by Company in 2023 (K Pcs)
Figure 28. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company in 2023
Figure 29. Human Cytomegalovirus Envelope Glycoprotein B Revenue Market by Company in 2023 ($ Million)
Figure 30. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company in 2023
Figure 31. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales 2019-2024 (K Pcs)
Figure 34. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue 2019-2024 ($ Millions)
Figure 35. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales 2019-2024 (K Pcs)
Figure 36. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue 2019-2024 ($ Millions)
Figure 37. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales 2019-2024 (K Pcs)
Figure 38. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales 2019-2024 (K Pcs)
Figure 40. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue 2019-2024 ($ Millions)
Figure 41. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2023
Figure 42. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country in 2023
Figure 43. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2024)
Figure 44. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2019-2024)
Figure 45. United States Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region in 2023
Figure 50. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Regions in 2023
Figure 51. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2024)
Figure 52. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2019-2024)
Figure 53. China Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 57. India Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2023
Figure 61. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country in 2023
Figure 62. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2024)
Figure 63. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2019-2024)
Figure 64. Germany Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 65. France Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2023
Figure 70. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2019-2024)
Figure 73. Egypt Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B in 2023
Figure 79. Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
Figure 80. Industry Chain Structure of Human Cytomegalovirus Envelope Glycoprotein B
Figure 81. Channels of Distribution
Figure 82. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Forecast by Region (2025-2030)
Figure 83. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Human Cytomegalovirus Envelope Glycoprotein B
Figure 2. Human Cytomegalovirus Envelope Glycoprotein B Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Growth Rate 2019-2030 (K Pcs)
Figure 7. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of CSJ-148
Figure 10. Product Picture of CyMVectin
Figure 11. Product Picture of TRL-345
Figure 12. Product Picture of PPCM
Figure 13. Product Picture of Cytomegalovirus Vaccine
Figure 14. Product Picture of Others
Figure 15. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type in 2023
Figure 16. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2019-2024)
Figure 17. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Infectious Disease
Figure 18. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Infectious Disease (2019-2024) & (K Pcs)
Figure 19. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Oncology
Figure 20. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Oncology (2019-2024) & (K Pcs)
Figure 21. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Women's Health
Figure 22. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Women's Health (2019-2024) & (K Pcs)
Figure 23. Human Cytomegalovirus Envelope Glycoprotein B Consumed in Others
Figure 24. Global Human Cytomegalovirus Envelope Glycoprotein B Market: Others (2019-2024) & (K Pcs)
Figure 25. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2023)
Figure 26. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application in 2023
Figure 27. Human Cytomegalovirus Envelope Glycoprotein B Sales Market by Company in 2023 (K Pcs)
Figure 28. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Company in 2023
Figure 29. Human Cytomegalovirus Envelope Glycoprotein B Revenue Market by Company in 2023 ($ Million)
Figure 30. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Company in 2023
Figure 31. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales 2019-2024 (K Pcs)
Figure 34. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue 2019-2024 ($ Millions)
Figure 35. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales 2019-2024 (K Pcs)
Figure 36. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue 2019-2024 ($ Millions)
Figure 37. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales 2019-2024 (K Pcs)
Figure 38. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales 2019-2024 (K Pcs)
Figure 40. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue 2019-2024 ($ Millions)
Figure 41. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2023
Figure 42. Americas Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country in 2023
Figure 43. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2024)
Figure 44. Americas Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2019-2024)
Figure 45. United States Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region in 2023
Figure 50. APAC Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Regions in 2023
Figure 51. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2024)
Figure 52. APAC Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2019-2024)
Figure 53. China Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 57. India Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2023
Figure 61. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country in 2023
Figure 62. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2024)
Figure 63. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2019-2024)
Figure 64. Germany Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 65. France Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country in 2023
Figure 70. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2019-2024)
Figure 73. Egypt Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B in 2023
Figure 79. Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
Figure 80. Industry Chain Structure of Human Cytomegalovirus Envelope Glycoprotein B
Figure 81. Channels of Distribution
Figure 82. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Forecast by Region (2025-2030)
Figure 83. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share Forecast by Application (2025-2030)
